The results of these different studies may suggest that the activation of NLRP3 in different tissues of SSc patients varies and is related to the specific disease progression, such as higher expression levels of IL-1β and caspase-1 in the muscle tissue of SSc patients with myositis [164]. This evidence concerns the gene CASP1 and systemic sclerosis.